Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents.
Prolonged cold storage of plasma may induce the conversion of plasma prorenin (inactive renin) to renin. This phenomenon is exaggerated in oral contraceptive (OC) users; the titer of Hageman factor (HF, Factor XII) in OC users is higher than in nonusers. The present study relates these observations. The increment in plasma renin activity (PRA) during cold storage, as measured by generation of angiotensin I, correlated strongly with the initial plasma titer of HF. Increasing the HF titer of nonusers to that observed in OC users by addition of purified HF increased cold-induced PRA at least twofold, while reducing the plasma HF titer of OC users correspondingly decreased cold-induced PRA. Thus, in OC users, the enhanced conversion of plasma prorenin to renin during cold storage reflects the elevated plasma titer of HF.
D000803:Angiotensin I / Q000097:blood; D003080:Cold Temperature; D003174:Complement C1 Inactivator Proteins / Q000097:blood; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004792:Enzyme Precursors / Q000097:blood*; D005174:Factor XII / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D012083:Renin / Q000097:blood*
D003174:Complement C1 Inactivator Proteins; D003276:Contraceptives, Oral; D004792:Enzyme Precursors; D005174:Factor XII; D000803:Angiotensin I; D012083:Renin